Skip to main content

Table 1 Characteristics of the included studies on MRSA prevalence

From: Prevalence, predictors, and mortality of bloodstream infections due to methicillin-resistant Staphylococcus aureus in patients with malignancy: systemic review and meta-analysis

Region/Study

Country

Study perioid

Setting

No. of BSI isolates

No. of GP bacteria (%)

No. of MRSA (%)

MRSA rates in S. aureus

Africa

 El-Mahallawy et al. 2005 [43]

Egypt

1999

Children with ST or HM

328

168 (51.2)

18 (5.5)

40.9%

 Arega et al. 2018 [49]

Ethiopia

2011–2012

Adults with ST or HM

82

43 (52.4)

23 (28.0)

74.2%

 Obeng-Nkrumah et al. 2015 [41]

Ghana

2010–2013

Adults and children with ST or HM

93

40 (43.0)

0 (0.0)

NA

 Mvalo et al. 2018 [38]

South Africa

2012–2014

Children with ST or HM

173

85 (49.1)

2 (1.2)

NA

 Lubwama et al. 2019 [30]

Uganda

2014

Adults and children with ST or HM

33

11 (33.3)

1 (3.0)

NA

Americas

 Velasco et al. 2004 [35]

Brazil

2000–2002

Adults and children with ST or HM

1036

328 (31.7)

17 (1.6)

18.7%

 Islas-Munoz et al. 2018 [5]

Mexico

2016–2017

Adults with ST or HM

496

135 (27.2)

4 (0.8)

8.0%

Europe

 Anatoliotaki et al. 2004 [42]

Greece

1995–2000

Adults with ST

157

54 (34.4)

12 (7.6)

85.7%

 Schelenz et al. 2013 [48]

UK

1997–2010

Adults with ST or HM

949

560 (59.0)

26 (2.7)

32.1%

 Miedema et al. 2013 [34]

Netherlands;

Switzerland

2004–2011

Children with ST or HM and FN

248

180 (72.6)

0 (0.0)

NA

 Horasan et al. 2011 [36]

Turkey

2004–2009

Adults with ST or HM and FN

98

47 (48.0)

3 (3.1)

NA

 Kara et al. 2015 [46]

Turkey

2005–2009

Adults with HM and FN

536

192 (35.8)

7 (1.3)

23.3%

 Bodro et al. 2014 [47]

Spain

2006–2011

Adults with ST or HM

1148

NA

13 (1.1)

12.3%

 Gedik et al. 2014 [40]

Turkey

2010–2012

Adults with HM and FN

90

17 (18.9)

4 (4.4)

NA

Western Pacific

 Lai et al. 2003 [31]

Taiwan, China

1999

Children with ST or HM and FN

46

11 (23.9)

3 (6.5)

NA

 Wang et al. 2005 [33]

Taiwan, China

1999–2002

Adults with HM

418

87 (20.8)

39 (9.3)

73.6%

 Huang et al. 2011 [29]

Taiwan, China

2003–2005

Adults with ST or HM

588

153 (26.0)

24 (4.1)

55.8%

 Baskaran et al. 2007 [32]

Malaysia

2004–2005

Adults with HM and FN

73

29 (39.7)

0 (0.0)

NA

 Yamamoto et al. 2010 [39]

Japan

2003–2007

Adults with HM

119

89 (74.8)

14 (11.8)

82.4%

 Kang et al. 2012 [13]

South Korea

2006–2007;

2008–2009

Adults with ST or HM

1246

408 (32.7)

59 (4.7)

48.4%

 Kwon et al. 2013 [45]

South Korea

2009–2010

Adults with HM

243

122 (50.2)

7 (2.9)

63.6%

 Chen et al. 2017 [44]

Taiwan, China

2008–2013

Adults with HM

2090

841 (40.2)

24 (1.1)

42.1%

South-east Asia

 Bhat et al. 2016 [37]

India

2012–2014

Adults with ST or HM and FN

128

51 (39.8)

10 (7.8)

31.3%

Eastern Mediterranean

 Greenberg et al. 2005 [50]

Israel

1998–2002

Children with ST or HM and FN

132

39 (29.5)

0 (0.0)

NA

  1. BSI bloodstream infection, GP Gram-positive, MRSA methicillin-resistant Staphylococcus aureus, ST solid tumors, HM hematological malignancy, FN febrile neutropenia, NA not applicable